Novartis has announced an intention to separate the Sandoz business to create a standalone company by way of a 100% spin-off.

2023 Extraordinary General Meeting

Date: Friday, September 15, 2023, 10:00 CEST
Place: St. Jakobshalle, Basel, Switzerland
Learn more

Listing prospectus of Sandoz Group AG
Supplement to Listing prospectus of Sandoz Group AG
Second Supplement to Listing prospectus of Sandoz Group AG
Shareholder Information Brochure (English | German

Sandoz Capital Markets Day

Sandoz hosted two Capital Markets Days (CMDs), on June 8 and June 12, at the New York stock exchange and the London stock exchange. The goal of both events was to outline its strong heritage, reshaped growth strategy and plans for sustainable market leadership, following the proposed 100% spin-off from Novartis in the second half of this year.
Capital Markets Day Presentation

Recordings

Audio file
Capital Markets Day - London

 

Audio file
Capital Markets Day - New York

Updates

August 25, 2022
LinkedIn article from Richard Saynor on proposed spin-off

Meet Novartis Management

September 22, 2022
Read the media release
Watch a replay of the webcast

Media Release

August 25, 2022
English | German

Investors

August 25, 2022
Watch the webcast
Download the presentation (PDF 1.1 MB)